Prognostic Value of a Multidimensional Assessment for Survival in Elderly Patients With CKD 4B/5

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE BESANCON · Feb 10, 2025

Keywords

ClinConnect Summary

This clinical trial is focused on understanding how a thorough assessment can help predict survival outcomes for elderly patients with advanced chronic kidney disease (CKD) stages 4B and 5. The goal is to develop a better way to identify patients who may need treatments like dialysis or transplantation, or those who may be more likely to pass away due to their kidney condition. The study will look at various factors, including the patient's overall health and self-reported experiences, to create a comprehensive picture of their situation.

To participate in this study, patients need to have CKD stage 4B or 5 and must be able to speak French. They also need to be part of the French social security system and agree to join the study. However, individuals who are unable to understand the study, those with certain psychiatric disorders, or those without social security coverage will not be eligible. While the study is not yet recruiting participants, those who do join can expect to contribute to important research that could improve care for others with similar health challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with CKD stage 4B or 5 (first consultation with GFR \< 20 mL/min /1.73 m2 in CKD-EPI 2009).
• • Fluency in French
• • Membership of a French social security scheme
• • Non-opposition from the subject to participate in the study
• Exclusion Criteria:
• • Subjects with limited legal capacity.
• • Subjects still in the exclusion period of another study, or according to the national registry of clinical trial participants.
• • Subjects with no social security coverage.
• • Subjects judged by the investigator to be unlikely to comply with study procedures
• • Subjects unable to understand the reasons for the study; psychiatric disorders judged by the investigator to be incompatible with inclusion in the study.